Cyclosporine Not Yet Recruiting Phase 3 Trials for Toxic Epidermal Necrolysis / Stevens-Johnson Syndrome Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02987257NATIENS: Optimal Management and Mechanisms of SJS/TEN